Clinical Trial Update: Dendritic Cells for Type 1 Diabetes Mellitus (T1DM) Therapy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating dendritic cell therapy for Type 1 diabetes mellitus; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Dendritic cell therapy

Snippet

Sponsor: DiaVacs, Inc. | Conditions: Treatment of Type I Diabetes Mellitus. | Phase 1, Phase 2 | Status: UNKNOWN